Rifapentine and Isoniazid for Latent Tuberculosis

被引：0
|
作者：
Mirsaeidi, Mehdi [1 ]
机构：
[1] Univ Illinois, Chicago, IL 60607 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2012年 / 366卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1447 / 1448
页数：2
相关论文
共 50 条
  • [41] Genetic and clinical predictors of rifapentine and isoniazid pharmacokinetics in paediatrics with tuberculosis infection
    Phaisal, Weeraya
    Albitar, Orwa
    Chariyavilaskul, Pajaree
    Jantarabenjakul, Watsamon
    Wacharachaisurapol, Noppadol
    Ghadzi, Siti Maisharah Sheikh
    Zainal, Hadzliana
    Harun, Sabariah Noor
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (06) : 1270 - 1278
  • [42] Adverse events associated with weekly short course isoniazid and rifapentine therapy in pediatric patients with latent tuberculosis: A chart and literature review
    Peck, Gabrielle M.
    Staat, Mary Allen
    Huang, Felicia Scaggs
    Khalil, Nadim
    Boyce, Catherine
    Kohlrieser, Cara M.
    Schlaudecker, Elizabeth P.
    PEDIATRIC PULMONOLOGY, 2021, 56 (08) : 2695 - 2699
  • [43] High Rate of Treatment Completion in Program Settings With 12-Dose Weekly Isoniazid and Rifapentine for Latent Mycobacterium tuberculosis Infection
    Sandul, Amy L.
    Nwana, Nwabunie
    Holcombe, Mike
    Lobato, Mark N.
    Marks, Suzanne
    Webb, Risa
    Wang, Shu-Hua
    Stewart, Brock
    Griffin, Phil
    Hunt, Garrett
    Shah, Neha
    Marco, Asween
    Patil, Naveen
    Mukasa, Leonard
    Moro, Ruth N.
    Jereb, John
    Mase, Sundari
    Chorba, Terence
    Bamrah-Morris, Sapna
    Ho, Christine S.
    CLINICAL INFECTIOUS DISEASES, 2017, 65 (07) : 1085 - 1093
  • [44] Short-Course Isoniazid Plus Rifapentine Directly Observed Therapy for Latent Tuberculosis in Solid-Organ Transplant Candidates
    de Castilla, Diego Lopez
    Rakita, Robert M.
    Spitters, Christopher E.
    Narita, Masahiro
    Jain, Rupali
    Limaye, Ajit P.
    TRANSPLANTATION, 2014, 97 (02) : 206 - 211
  • [45] The Cost To Implement A 12-Dose Weekly Isoniazid And Rifapentine (3hp) Regimen For Latent Tuberculosis Infection (ltbi)
    Marks, S. M.
    Sandul, A.
    Shah, N.
    Nwana, N.
    Mukasa, L.
    Bertsch, T.
    Ho, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [46] High Completion Rate for 12 Weekly Doses of Isoniazid and Rifapentine as Treatment for Latent Mycobacterium tuberculosis Infection in the Federal Bureau of Prisons
    Schmit, Kristine M.
    Lobato, Mark N.
    Lang, Simona G.
    Wheeler, Sherri
    Kendig, Newton E.
    Bur, Sarah
    JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE, 2019, 25 (02): : E1 - E6
  • [47] Iadhere Study: Cost-Effectiveness Of Self-Administered Isoniazid/rifapentine For Treatment Of Latent Tuberculosis Infection In The United States
    Holland, D. P.
    Sheehan, D.
    Wright, A.
    Scott, N. A.
    Belknap, R. W.
    Borisov, A. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [48] Association of Drug Metabolic Enzyme Genetic Polymorphisms and Adverse Drug Reactions in Patients Receiving Rifapentine and Isoniazid Therapy for Latent Tuberculosis
    Yu, Ya-Yen
    Tsao, Shih-Ming
    Yang, Wen-Ta
    Huang, Wei-Chang
    Lin, Ching-Hsiung
    Chen, Wei-Wen
    Yang, Shun-Fa
    Chiou, Hui-Ling
    Huang, Yi-Wen
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (01)
  • [49] Drug–Drug Interaction Potential with Once-Weekly Isoniazid/Rifapentine (3HP) for the Treatment of Latent Tuberculosis Infection
    Catia Marzolini
    Sara Gibbons
    Joep J. van Oosterhout
    Saye Khoo
    Clinical Pharmacokinetics, 2022, 61 : 339 - 346
  • [50] AN INHALABLE RIFAPENTINE DRY POWDER TARGETING LATENT TUBERCULOSIS INFECTION
    Chan, John G. Y.
    Tyne, Anneliese S.
    Pang, Angel
    Duke, Colin
    Britton, Warwick J.
    Chan, Hak Kim
    Young, Paul M.
    Traini, Daniela
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2014, 27 (04) : A12 - A13
12345